Search Results - "BIERSACK, Harald" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing

Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing

by Gebauer, Niklas, Künstner, Axel, Ketzer, Julius, Witte, Hanno M., Rausch, Tobias, Benes, Vladimir, Zimmermann, Jürgen, Gebauer, Judith, Merz, Hartmut, Bernard, Veronica, Harder, Lana, Ratjen, Katharina, Gesk, Stefan, Peter, Wolfgang, Busch, Yannik, Trojok, Peter, von Bubnoff, Nikolas, Biersack, Harald, Busch, Hauke, Feller, Alfred C.
Published in Blood cancer journal (New York) (26.05.2021)

Get full text

Journal Article

Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly

Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly

by Gebauer, Niklas, Gebauer, Judith, Hardel, Tim Tristan, Bernard, Veronica, Biersack, Harald, Lehnert, Hendrik, Rades, Dirk, Feller, Alfred Christian, Thorns, Christoph
Published in Leukemia & lymphoma (01.04.2015)

Get full text

Journal Article

Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors

Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors

by Bartscht, Tobias, Rosien, Benjamin, Rades, Dirk, Kaufmann, Roland, Biersack, Harald, Lehnerta, Hendrik, Ungefroren, Hendrik
Published in Anti-cancer agents in medicinal chemistry (01.01.2017)

Get more information

Journal Article

TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271

TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271

by Bartscht, Tobias, Rosien, Benjamin, Rades, Dirk, Kaufmann, Roland, Biersack, Harald, Lehnert, Hendrik, Ungefroren, Hendrik
Published in Anti-cancer agents in medicinal chemistry (01.01.2017)

Get more information

Journal Article

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

by DE WITTE, Theo, HAGEMEIJER, Anne, AMADORI, Sergio, MUUS, Petra, JANSEN, Joop H, HELLSTRÖM-LINDBERG, Eva, KOVACSOVICS, Tibor, WIJERMANS, Pierre, OSSENKOPPELE, Gert, GRATWOHL, Alois, MARIE, Jean-Pierre, WILLEMZE, Roel, SUCIU, Stefan, BELHABRI, Amin, DELFORGE, Michel, KOBBE, Guido, SELLESLAG, Dominik, SCHOUTEN, Harry C, FERRANT, Augustin, BIERSACK, Harald
Published in Haematologica (Roma) (01.10.2010)

Get full text

Journal Article

Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

by Finke, Jürgen, Schmoor, Claudia, Ayuk, Francis, Hasenkamp, Justin, Verbeek, Mareike, Wagner, Eva-Maria, Biersack, Harald, Schäfer-Eckart, Kerstin, Wolf, Dominik, Stuhler, Gernot, Reibke, Roland, Schmid, Christoph, Kaufmann, Martin, Eder, Matthias, Bertz, Hartmut, Grishina, Olga
Published in Bone marrow transplantation (Basingstoke) (01.08.2024)

Get full text

Journal Article

Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

by Finke, Jürgen, Schmoor, Claudia, Ayuk, Francis, Hasenkamp, Justin, Verbeek, Mareike, Wagner, Eva-Maria, Biersack, Harald, Schäfer-Eckart, Kerstin, Wolf, Dominik, Stuhler, Gernot, Reibke, Roland, Schmid, Christoph, Kaufmann, Martin, Eder, Matthias, Bertz, Hartmut, Grishina, Olga
Published in Bone marrow transplantation (Basingstoke) (01.07.2024)

Get full text

Journal Article

Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein‐Barr‐Virus positive diffuse large B cell lymphoma

Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein‐Barr‐Virus positive diffuse large B cell lymphoma

by Witte, Hanno M., Merz, Hartmut, Biersack, Harald, Bernard, Veronica, Riecke, Armin, Gebauer, Judith, Lehnert, Hendrik, Bubnoff, Nikolas, Feller, Alfred C., Gebauer, Niklas
Published in British journal of haematology (01.04.2020)

Get full text

Journal Article

Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action

Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action

by Bartscht, Tobias, Rosien, Benjamin, Rades, Dirk, Kaufmann, Roland, Biersack, Harald, Lehnert, Hendrik, Gieseler, Frank, Ungefroren, Hendrik
Published in Molecular cancer (21.11.2015)

Get full text

Journal Article

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma

by Witte, Hanno, Biersack, Harald, Kopelke, Svenja, Rades, Dirk, Merz, Hartmut, Bernard, Veronica, Lehnert, Hendrik, Fetscher, Sebastian, Gebauer, Niklas
Published in British journal of haematology (01.03.2019)

Get full text

Journal Article

Exhaustion of tumour‐infiltrating T‐cell receptor repertoire diversity is an age‐dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma

Exhaustion of tumour‐infiltrating T‐cell receptor repertoire diversity is an age‐dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma

by Rieken, Johannes, Bernard, Veronica, Witte, Hanno M., Peter, Wolfgang, Merz, Hartmut, Olschewski, Vito, Hertel, Lars, Lehnert, Hendrik, Biersack, Harald, Bubnoff, Nikolas, Feller, Alfred C., Gebauer, Niklas
Published in British journal of haematology (01.04.2021)

Get full text

Journal Article

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma

Indolent lymphoma with composite histology and simultaneous transformation at initial diagnosis exhibit clinical features similar to de novo diffuse large B-cell lymphoma

by Witte, Hanno, Biersack, Harald, Kopelke, Svenja, Rades, Dirk, Merz, Hartmut, Bernard, Veronica, Lehnert, Hendrik, Gebauer, Niklas
Published in Oncotarget (13.04.2018)

Get full text

Journal Article

Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae

Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae

by Jensen, Sanne, Andersen, Anni H., Kjeldsen, Eigil, Biersack, Harald, Olsen, Eva H. N., Andersen, Torben B., Westergaard, Ole, Jakobsen, Bent K.
Published in Molecular and Cellular Biology (01.07.1996)

Get full text

Journal Article

The Integrated Glasgow Prognostic- and Cytogenetic Risk Score (CytoGPS) at Diagnosis Is a Strong and Independent Predictor of Survival in Transplant-Eligible Patients with Multiple Myelom

The Integrated Glasgow Prognostic- and Cytogenetic Risk Score (CytoGPS) at Diagnosis Is a Strong and Independent Predictor of Survival in Transplant-Eligible Patients with Multiple Myelom

by Witte, Hanno Maximilian, Biersack, Harald, Riecke, Armin, Bonorden, Bastian, Kopelke, Svenja, Merz, Hartmut, Bernard, Veronica, Lehnert, Hendrik, Kull, Miriam, Fetscher, Sebastian, Gebauer, Niklas
Published in Blood (29.11.2018)

Get full text

Journal Article

Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma

Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma

by Witte, Hanno M., Riecke, Armin, Mayer, Thomas, Bartscht, Tobias, Rades, Dirk, Lehnert, Hendrik, Merz, Hartmut, Fetscher, Sebastian, Biersack, Harald, Gebauer, Niklas
Published in Journal of cancer research and clinical oncology (01.01.2019)

Get full text

Journal Article

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements

Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements

by Olschewski, Vito, Witte, Hanno M, Bernard, Veronica, Steinestel, Konrad, Peter, Wolfgang, Merz, Hartmut, Rieken, Johannes, Biersack, Harald, von Bubnoff, Nikolas, Feller, Alfred C, Gebauer, Niklas
Published in Cancers (20.02.2021)

Get full text

Journal Article

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

by Braess, Jan, Amler, Susanne, Kreuzer, Karl-Anton, Spiekermann, Karsten, Lindemann, Hans Walter, Lengfelder, Eva, Graeven, Ullrich, Staib, Peter, Ludwig, Wolf-Dieter, Biersack, Harald, Ko, Yon-Dschun, Uppenkamp, Michael J., De Wit, Maike, Korsten, Stefan, Peceny, Rudolf, Gaska, Tobias, Schiel, Xaver, Behringer, Dirk M., Kiehl, Michael G., Zinngrebe, Bettina, Meckenstock, Gerald, Roemer, Eva, Medgenberg, Dirk, Spaeth-Schwalbe, Ernst, Massenkeil, Gero, Hindahl, Heidrun, Schwerdtfeger, Rainer, Trenn, Guido, Sauerland, Cristina, Koch, Raphael, Lablans, Martin, Faldum, Andreas, Görlich, Dennis, Bohlander, Stefan K., Schneider, Stephanie, Dufour, Annika, Buske, Christian, Fiegl, Michael, Subklewe, Marion, Braess, Birgit, Unterhalt, Michael, Baumgartner, Anja, Wörmann, Bernhard, Beelen, Dietrich, Hiddemann, Wolfgang
Published in Leukemia (01.12.2018)

Get full text

Journal Article

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation

The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation

by Witte, Hanno M, Bonorden, Bastian, Riecke, Armin, Biersack, Harald, Steinestel, Konrad, Merz, Hartmut, Feller, Alfred C, Bernard, Veronica, Fetscher, Sebastian, von Bubnoff, Nikolas, Gebauer, Niklas
Published in Cancers (09.04.2020)

Get full text

Journal Article

Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)

Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)

by Stübig, Thomas, Langer, Christian, Engelhardt, Monika, Mügge, Lars-Olof, Bassermann, Florian, Schreder, Martin, Schäfer-Eckart, Kerstin, Blau, Igor Wolfgang, Wolleschak, Denise, Reichle, Albrecht, Metzler, Ivana, Metzner, Bernd, Rollig, Christoph, Hertenstein, Bernd, Dürk, Heinz, Biersack, Harald, Menzel, Helge, Dechow, Tobias, Schleicher, Jan, Gramatzki, Martin, Brümmendorf, Tim H., Fuhrmann, Stephan, Bittrich, Max, Appelt, Franziska, Müller, Martina, Krönke, Jan, Reusch, Julia, Schmidt, Christian, Brüggemann, Monika, Held, Swantje, Knop, Stefan, Einsele, Hermann
Published in Blood (29.11.2018)

Get full text

Journal Article

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective

by Gebauer, Niklas, Biersack, Harald, Czerwinska, Ann-Cathrin, Schemme, Janina, Hardel, Tim Tristan, Bernard, Veronica, Rades, Dirk, Lehnert, Hendrik, Luley, Kim Barbara, Thorns, Christoph
Published in Leukemia & lymphoma (02.01.2016)

Get full text

Journal Article